<DOC>
	<DOCNO>NCT01775904</DOCNO>
	<brief_summary>The purpose study evaluate two different formulation LY2886721 . In addition , study determine much study drug ( LY2886721 ) get blood steam long body take get rid take formulation without meal . Information side effect may occur also collect . Each participant may involve study approximately 7 week . This study require 4 period . In period , participant receive LY2886721 tablet capsule , without food water . There 7 day washout period .</brief_summary>
	<brief_title>A Study Two Dosage Forms LY2886721 Healthy Participants</brief_title>
	<detailed_description />
	<criteria>Have body mass index ( BMI ) 18.5 32.0 kilogram per square meter ( kg/m^2 ) , inclusive , screen At least 4 participant great 55 year age Male participant : Agree use reliable method birth control donate sperm study 3 month follow last dose investigational product Female participant : Women childbearing potential due surgical sterilization ( least 6 week surgical bilateral oophorectomy , hysterectomy , ) confirm medical history , postmenopausal female , determine medical history physical examination ( spontaneous amenorrhea 6 12 month follicle stimulate hormone [ FSH ] level great 40 milliinternational unit per milliliter [ mIU/mL ] ) Have venous access sufficient allow blood sample per protocol Are currently enrol , complete , discontinue within last 30 day clinical trial involve investigational product ; concurrently enrol type medical research judge scientifically medically compatible study Have participate , within last 30 day , clinical trial involve investigational product Have know allergy LY2886721 , related compound , component formulation Have abnormality 12lead electrocardiogram ( ECG ) Have significantly abnormal blood pressure determine investigator Have history current cardiovascular , respiratory , hepatic , renal , gastrointestinal , endocrine , hematological , neurological disorder capable significantly alter absorption , metabolism , elimination drug ; constitute risk take study medication ; interfere interpretation data Regularly use know drug abuse and/or show positive finding urinary drug screen Show evidence human immunodeficiency virus ( HIV ) infection and/or positive human HIV antibody Show evidence hepatitis B C and/or positive hepatitis B C antibody Have history , current , significant ophthalmologic disease Show evidence significant active neuropsychiatric disease history suicide attempt</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2013</verification_date>
</DOC>